Company page

Biomark Diagnostics, Inc.

Biomark Diagnostics, Inc. is a public company traded under the ticker BUX on the Canadian market. The company has a market capitalization of approximately CAD 44.95 million. Biomark focuses on developing innovative diagnostic solutions in the healthcare sector.